Advances in Pharmacological and Pharmaceutical Sciences / 2012 / Article / Fig 2

Review Article

An Overview of the CNS-Pharmacodynamic Profiles of Nonselective and Selective GABA Agonists

Figure 2

ΔVASalertness-ΔSPV relative effect profile of TPA023 1.5 mg, TPACMP2 0.75 mg, SL65.1498 25 mg, zolpidem 10 mg, and alprazolam 1 mg versus lorazepam 2 mg, respectively. (Blue open square: investigational compound; red closed circle: lorazepam 2 mg; blue dot line: the comparator drug, red dash line; lorazepam 2 mg.)
134523.fig.002a
(a)
134523.fig.002b
(b)
134523.fig.002c
(c)
134523.fig.002d
(d)
134523.fig.002e
(e)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.